Production (Stage)
Compass Therapeutics, Inc.
CMPX
$2.37
-$0.04-1.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.64% | -43.46% | 19.86% | -21.22% | 19.59% |
| Total Depreciation and Amortization | 1.39% | -22.80% | -0.21% | 0.65% | -1.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.07% | 2.50% | 37.73% | -14.32% | 106.47% |
| Change in Net Operating Assets | -85.30% | 219.85% | -740.04% | 108.90% | -2,562.05% |
| Cash from Operations | -44.16% | 17.09% | -2.76% | 22.57% | -12.42% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.49% | -47.11% | 348.28% | 258.16% | -164.83% |
| Cash from Investing | -24.61% | -47.03% | 347.60% | 258.16% | -164.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -748.96% | -- | -- | 100.00% | 14.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -300.00% | 100.18% | -54,500.00% |
| Cash from Financing | -767.02% | -4,600.00% | -300.00% | -99.99% | 11,133.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.83% | -65.97% | 520.73% | -670.76% | 91.06% |